IN-HOSPITAL OUTCOMES OF CAROTID ARTERY STENTING IN PATIENTS WITH A CONTRALATERAL CAROTID OCCLUSION: ANALYSIS FROM THE CAROTID ARTERY REVASCULARIZATION AND ENDARTERECTOMY (CARE) REGISTRY  by Mercado, Nestor et al.
E1421
JACC April 5, 2011
Volume 57, Issue 15
  VASCULAR DISEASE
IN-HOSPITAL OUTCOMES OF CAROTID ARTERY STENTING IN PATIENTS WITH A CONTRALATERAL 
CAROTID OCCLUSION: ANALYSIS FROM THE CAROTID ARTERY REVASCULARIZATION AND 
ENDARTERECTOMY (CARE) REGISTRY
ACC Oral Contributions
Ernest N. Morial Convention Center, Room 244
Tuesday, April 05, 2011, 11:45 a.m.-Noon
Session Title: Peripheral Arterial Disease: Update and New Therapies
Abstract Category: 11. Peripheral Arterial/Carotid Disease/Aortic Disease
Presentation Number: 925-7
Authors: Nestor Mercado, David J. Cohen, John A. Spertus, John House, Kevin Kennedy, Paul S. Chan, Kenneth A. Rosenfield, Steven P. Marso, Saint 
Luke’s Mid America Heart and Vascular Institute, Kansas City, MO, Division of Cardiology, Massachusetts General Hospital, Boston, MA
Background:  Contralateral carotid occlusion (CCO) is a predictor of adverse neurologic outcomes following carotid endarterectomy (CEA). The 
prevalence and outcomes of carotid artery stenting (CAS) in patients with CCO have not been well defined.
Methods:  Using the ACC NCDR Carotid Artery Revascularization and Endarterectomy (CARE) registry, we compared the combined outcome of in-
hospital death, non-fatal stroke and myocardial infarction in patients with and without CCO undergoing CAS. A CCO was defined as 100% occlusion 
of the patient’s contralateral carotid artery. To further clarify the impact of the treated lesion’s severity, we also stratified the analysis by patient 
symptoms.
Results:  Between 05/2005 and 03/2010, 7640 patients underwent CAS and were enrolled in CARE. Of these, 791 patients (12%) had a CCO prior 
to the index procedure. Patients with CCO were younger (average 69 years vs. 71 years, p<0.001), more often male (68% vs. 60%, p<0.001), current 
smokers (80% vs. 73%, p<0.001), more frequently had neurologic events prior to the CAS procedure (56% vs. 46%, p<0.001), and more often had 
ejection fractions ≤ 30% (16% vs. 11%, p<0.001). Patients with and without CCO had similar rates of the primary endpoint (35/791 [4.4%] with 
CCO; 315/6669 [4.7%] without CCO; adjusted OR 0.94 [95% CI 0.65-1.37], p=0.76). There were no differences between the CCO groups among 
asymptomatic patients with a carotid stenosis of 60-99% (3.8% vs. 2.8%; adjusted OR 0.78 [0.42-1.43], p=0.42); and among symptomatic patients 
with a carotid stenosis of 50-99% (6.0% vs. 6.1%; adjusted OR 1.06 [0.65-1.72], p=0.81).
Conclusion: Although more than 1 in 10 CAS procedures are done in the setting of CCO, there does not appear to be an increased risk for 
cardiovascular morbidity and mortality associated with CAS in these patients. Although careful patient selection may influence these results, 
performing CAS in this setting of CCO may be as safe as in a patient without CCO.
